AavantiBio, Inc. of GAINESVILLE, FL, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-19. The offering totals $106.9M, of which $41.8M was reported sold. Industry: Biotechnology.
| Name | Role | Location |
|---|---|---|
| Barry J Byrne, M.D., Ph.D. | Director | GAINESVILLE, FL |
| Manuela J Corti, PT, Ph.D. | Director | GAINESVILLE, FL |
| Bo Cumbo | Director | GAINESVILLE, FL |
| Ellen J Hukkelhoven, Ph.D. | Director | GAINESVILLE, FL |
| Philip R Johnson, M.D. | Director | Philadelphia, PA |
| Benjamin R Lund | Director | Philadelphia, PA |
| Jake R Simson | Director | GAINESVILLE, FL |
| Douglas J Swirsky | Director | Florham Park, NJ |
| Barry J Byrne, M.D., Ph.D. | Executive Officer | GAINESVILLE, FL |
| Manuela J Corti, PT, Ph.D. | Executive Officer | GAINESVILLE, FL |
| Bo Cumbo | Executive Officer | GAINESVILLE, FL |
| Ellen J Hukkelhoven, Ph.D. | Executive Officer | GAINESVILLE, FL |
| Philip R Johnson, M.D. | Executive Officer | Philadelphia, PA |
| Benjamin R Lund | Executive Officer | Philadelphia, PA |
| Jake R Simson | Executive Officer | GAINESVILLE, FL |
| Douglas J Swirsky | Executive Officer | Florham Park, NJ |